Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
VX-765
DRUG
2 trials
Sponsors
Vertex Pharmaceuticals Incorporated
Conditions
Partial Epilepsy
Psoriasis
Phase 2
Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765
Completed
NCT00205465
Vertex Pharmaceuticals Incorporated
Psoriasis
Start: 2004-12-31
End: 2005-09-30
Target: 64
Updated: 2007-12-05
Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy
Completed
NCT01048255
Vertex Pharmaceuticals Incorporated
Partial Epilepsy
Start: 2010-01-31
End: 2010-11-30
Updated: 2014-01-27